Biogen Inc. buy UBS Group AG
Start price
22.04.26
/
50%
€162.56
Target price
22.04.27
€191.59
Performance (%)
12.00%
Price
15:54
€182.06
Summary
This prediction is currently active. The prediction currently has a performance of 12.00%. This prediction currently runs until 22.04.27. The prediction end date can be changed by UBS_Group_AG at any time. UBS_Group_AG has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Biogen Inc. | 2.181% | 2.181% |
| iShares Core DAX® | 2.573% | 5.333% |
| iShares Nasdaq 100 | 4.858% | 0.449% |
| iShares Nikkei 225® | 5.590% | -0.586% |
| iShares S&P 500 | 3.250% | 2.500% |
Comments by UBS_Group_AG for this prediction
In the thread Biogen Inc. diskutieren
Biogen (BIIB) was upgraded by UBS Group AG from "neutral" to "buy". They now have a $225.00 price target on the stock.
Ratings data for BIIB provided by MarketBeat